Authors:
GARNERO P
GINEYTS E
SCHAFFER AV
SEAMAN J
DELMAS PD
Citation: P. Garnero et al., MEASUREMENT OF URINARY-EXCRETION OF NONISOMERIZED AND BETA-ISOMERIZEDFORMS OF TYPE-I COLLAGEN BREAKDOWN PRODUCTS TO MONITOR THE EFFECTS OFTHE BISPHOSPHONATE ZOLEDRONATE IN PAGETS-DISEASE, Arthritis and rheumatism, 41(2), 1998, pp. 354-360
Authors:
STOCK JL
AVIOLI LV
BAYLINK DJ
CHESNUT C
GENANT HK
MARICIC MJ
SILVERMAN SL
SCHAFFER AV
FEINBLATT J
Citation: Jl. Stock et al., CALCITONIN-SALMON NASAL SPRAY REDUCES THE INCIDENCE OF NEW VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN - 3-YEAR INTERIM RESULTS OF THE PROOF STUDY, Journal of bone and mineral research, 12, 1997, pp. 187-187
Authors:
SCHAFFER AV
BUCKLER H
RYAN W
RICHARDSON P
Citation: Av. Schaffer et al., A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL USING INTRAVENOUS ZOLEDRONATE(CGP-42446) IN PATIENTS WITH PAGETS-DISEASE OF BONE, Journal of bone and mineral research, 11, 1996, pp. 766-766
Authors:
SMITH SR
KUBACKI VB
RAKHIT A
MARTIN LL
SCHAFFER AV
JASANI MK
HEFTY DJ
JOHNSTON T
CANNON C
BENNETT WM
COFFMAN TM
Citation: Sr. Smith et al., CHRONIC THROMBOXANE SYNTHASE INHIBITION WITH CGS-12970 IN HUMAN CYCLOSPORINE NEPHROTOXICITY, Transplantation, 56(6), 1993, pp. 1422-1426
Authors:
SARIS SD
PIRAINO AJ
MORGAN JM
HIRSCHHORN WL
MEIDL E
SCHAFFER AV
Citation: Sd. Saris et al., URICOSURIC EFFECT OF CGS-12970, A NEW THROMBOXANE SYNTHASE INHIBITOR, Clinical pharmacology and therapeutics, 54(1), 1993, pp. 65-69